News &amp; Updates

Ultra-processed foods linked to constipation

Eating more ultra-processed foods leads to constipation, whereas greater consumption of minimally processed foods has the opposite effect, according to a cross-sectional study.

Ultra-processed foods linked to constipation

Dupilumab reduces exacerbations in type 2 asthma regardless of ICS dose

22 May 2024 by

Treatment with dupilumab significantly reduced the annual rate of severe exacerbations in children with uncontrolled, moderate-to-severe type 2 asthma who were on high- or medium-dose inhaled corticosteroid (ICS), according to a study presented at PAS 2024.

Dupilumab reduces exacerbations in type 2 asthma regardless of ICS dose

Short sleep duration throughout childhood a risk factor for psychosis

Sleeping less persistently throughout childhood may lead to the development of psychosis in early adulthood, according to a study.

Short sleep duration throughout childhood a risk factor for psychosis

Immune-mediated gut problems tied to eating disorders

People with immune-mediated gastrointestinal (GI) disease, especially children, are more prone to eating disorders, as shown in a study.

Immune-mediated gut problems tied to eating disorders

Poor mental health, vaccination reluctance felt by pharmacists during pandemic

Pharmacists have experienced worse mental well-being and a lack of willingness to vaccinate patients during the COVID-19 pandemic, reports a study.

Poor mental health, vaccination reluctance felt by pharmacists during pandemic

Vedolizumab helps induce steroid-free remission in children with IBD

Use of vedolizumab as maintenance treatment in children with inflammatory bowel disease (IBD) results in sustained steroid-free remission, with an acceptable safety profile, according to the results of the 54-week follow-up of the VedoKids Study presented at ESPGHAN 2024.

Vedolizumab helps induce steroid-free remission in children with IBD

21 May 2024

Infants, children with comorbidities at greatest risk for critical COVID-19

The risk of critical COVID-19 is highest among infants and adolescents, children with multiple comorbidities, those with a history of prematurity, diabetes, obesity, severe immunocompromise, and those with cardiovascular, neurologic, or chronic lung diseases, reveals a study presented at PAS 2024.

Infants, children with comorbidities at greatest risk for critical COVID-19

21 May 2024

Dalbavancin shows promise for complicated SAB management

Findings from the DOTS trial presented at ESCMID Global 2024 underpin the potential of dalbavancin, a long-acting lipoglycopeptide, for the management of complicated Staphylococcus (S.) aureus bacteraemia (SAB) without requiring long-term vascular access.

Dalbavancin shows promise for complicated SAB management